The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II study of SAR439859, an oral selective estrogen receptor degrader (SERD), in estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (mBC).
 
Mario Campone
Honoraria - Lilly; Novartis
Consulting or Advisory Role - Abbvie (Inst); Accord Healthcare (Inst); AstraZeneca/MedImmune (Inst); Lilly (Inst); Menarini; Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Sandoz-Novartis (Inst); Sanofi (Inst); SERVIER (Inst)
Speakers' Bureau - Amgen; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer
Other Relationship - Roche
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Genentech; Genentech/Roche (Inst); Immunomedics; Immunomedics (Inst); Innocrin Pharma (Inst); Merck; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Puma Biotechnology; Radius Health; Radius Health (Inst); Sanofi; Spectrum Pharmaceuticals
Research Funding - bioTheranostics
 
Gary A. Ulaner
Consulting or Advisory Role - Sanofi
Speakers' Bureau - Sanofi
Research Funding - Genentech; Puma Biotechnology; Sanofi
Patents, Royalties, Other Intellectual Property - GE Healthcare; Genentech; Novartis; Sanofi
 
Sarat Chandarlapaty
Consulting or Advisory Role - Bristol-Myers Squibb; Context Therapeutics; Lilly; Novartis; Paige.ai; Revolution Medicines; Sermonix Pharmaceuticals
Research Funding - Daiichi Sankyo (Inst); Genentech (Inst); Lilly (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Sun Pharma
 
Alice Gosselin
Employment - Sanofi
 
Séverine Doroumian
Employment - Sanofi
 
Vasiliki Pelekanou
Employment - Sanofi
 
Marina Celanovic
Employment - Sanofi
 
Hannah M. Linden
Leadership - Evolent (I)
Stock and Other Ownership Interests - Evolent (I)
Consulting or Advisory Role - AstraZeneca; Context Therapeutics; Eisai; Genomic Health; Syndax
Research Funding - Eisai; GTx (Inst); Sanofi/Aventis (Inst)